Rare diseases
Investigational molecules
Locations
66 Hudson Boulevard East, 10001-2189, United States
Arena Pharmaceuticals Inc. is active in clinical research for Crohn’s disease, with a focus on moderately to severely active inflammatory bowel disease and oral therapeutic options. The company’s trials examine treatment effects in adults with ongoing intestinal inflammation and related disease burden.
Its research activity includes multicenter work across international sites in patients with active gastrointestinal disease.
Arena Pharmaceuticals Inc. runs clinical trials in conditions such as Colitis ulcerative, Crohn's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
